GSK and CureVac join forces to develop vaccines targeting new COVID-19 variants
February 03, 2021 at 04:45 AM EST
GSK and CureVac said their approach could potentially tackle multiple coronavirus strains in one vaccine shot
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
